Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

The Beauty Health Company (SKIN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
11.790.00 (0.00%)
At close: 04:00PM EDT
11.79 0.00 (0.00%)
After hours: 07:32PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close11.79
Open11.64
Bid11.79 x 2200
Ask11.91 x 900
Day's Range11.64 - 12.49
52 Week Range9.94 - 30.17
Volume1,520,686
Avg. Volume1,539,547
Market Cap1.779B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SKIN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • The Beauty Health Company
    GXO: Lowering target price to $40.00GXO LOGISTICS INC has an Investment Rating of BUY; a target price of $40.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • Business Wire

    BeautyHealth Announces $200 Million Share Repurchase Authorization

    LONG BEACH, Calif., September 27, 2022--The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced its Board of Directors has authorized a share repurchase program of up to $200 million of the Company’s outstanding common stock. In connection with the share repurchase authorization, the Company entered into an accelerated share repurchase agreement ("ASR") with JPMorgan Chase Bank, N.A., to repurchase $100 million of the Company’s common stock. Upon completion

  • Business Wire

    A Harbinger of Beauty Industry Resiliency, BeautyHealth Announces Three-Year Plan to Double Sales, At Least Triple Profit

    LONG BEACH, Calif., September 15, 2022--The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today hosts its Analyst and Investor Day in New York City. At the event, BeautyHealth will provide an update on the significant progress the company is making on its five-point Master Plan and will announce new financial goals, namely our intent to double net sales and at least triple adjusted EBITDA by 2025.

  • Business Wire

    BeautyHealth’s Hydrafacial Announces Partnership to Develop Breakthrough Exosome Booster

    LONG BEACH, Calif., September 14, 2022--The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced a collaboration with biotech company Organicell to co-create a first-to-market exosome booster that will address signs of aging and inflammation in the skin. The booster will leverage novel exosome technology based on regenerative medical therapies and, once developed, will be available as a customized treatment addition for Hydrafacial.

Advertisement
Advertisement